You are here: Industry Insights > COVID-19

News List

Vaccinations move to nursing homes as pandemic rages in California expresspharma
December 22, 2020
President-elect Joe Biden became one of them, he received his shot on camera in an effort to boost confidence in its safety.
49 per cent of clinical trial disruption due to slow enrollment- GlobalData expresspharma
December 22, 2020
The fastest rate of trial disruption was between early April and mid-May, and the number of trials disrupted by COVID-19 peaked in the first week of June
Neutralizing antibodies protect against severe COVID-19 worldpharmanews
December 21, 2020
Understanding the body's immune response to SARS-CoV-2, the virus that causes COVID-19, is key to developing effective treatments and long-lasting vaccines.
Vir Biotechnology and GSK announce start of NIH-sponsored ACTIV-3 trial evaluating VIR-7831 in hospitalised adults with COVID-19 worldpharmanews
December 21, 2020
Vir Biotechnology, Inc. and GlaxoSmithKline plc announced that the first patient has been dosed in a new sub-trial of the National Institutes of Health's (NIH) Accelerating COVID-19 Therapeutic Interventions and Vaccines (ACTIV) Program Phase 3 ...
ImmuneMed's hzVSF-v13, COVID-19 clinical trials accelerate development of the treatment prnasia
December 21, 2020
The broad spectrum antiviral therapeutic, 'hzVSF-v13(humanized Virus Suppressing Factor)' being developed by ImmuneMed, is on track to progress as a treatment for the COVID-19 pneumonia patients.
NHS England invests ￡10m in network of ‘long COVID’ clinics pharmatimes
December 21, 2020
NHS England has announced a ￡10m investment in a network of clinics offering specialist support for long COVID, as new research shows one in five people with coronavirus develop longer term symptoms.
Ampion Demonstrates Safety In COVID-19 Patients, Initiates Global Trial for IV Ampion americanpharmaceuticalreview
December 21, 2020
Ampio Pharmaceuticals has completed its Phase I clinical trial and has initiated the first steps for a global Phase II clinical trial for intravenous (IV) Ampion treatment in COVID-19 patients.
AYUSH industry grew by 44 per cent in nine months of COVID-19 pandemic: AYUSH Secretary expresspharma
December 21, 2020
Speaking at an event organised by Assocham, he appealed to the industry to come forward and help in developing and propagating AYUSH drugs and medicines in the future.
US FDA gives EUA to Moderna’s mRNA vaccine against COVID-19 expresspharma
December 21, 2020
Total of 200 million doses ordered by the US government to date, approximately 20 million doses will be delivered by the end of December 2020.
US CDC gives recommendations for COVID-19 inoculation after allergic reactions expresspharma
December 21, 2020
People who have had a severe allergic reaction to any ingredient in a COVID-19 vaccine should avoid the vaccine formulation containing the ingredient, CDC said.